A0A2R9A4E1 (A0A2R9A4E1_PANPA) Pan paniscus (Pygmy chimpanzee) (Bonobo)

Thyroid hormone receptor beta UniProtKBInterProInteractive Modelling

461 aa; Sequence (Fasta) ; 7 identical sequences: Homo sapiens: P10828, A0A024R2I8; Pongo abelii: A0A2J8WZ26; Pan troglodytes: H2R3K3, A0A6D2WCL4; Gorilla gorilla gorilla: G3S6W6; Nomascus leucogenys: G1QTX5

Available Structures

32 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal Structure of the T3-bound TR-beta Ligand-binding Domain in complex with RXR-alpha Heteromer
P10828; P19793; Q15596;
210-461
100.0T3;
A novel agonist of THRb Heteromer
P10828; Q15596;
211-460
100.08HO;
A novel chemical derivative(92) of THRB agonist Heteromer
P10828; Q15596;
210-459
100.09IW;
A novel chemical derivative(89) of THRB agonist Heteromer
P10828; Q15596;
210-459
100.09IT;
THRb mutation with a novel agonist Heteromer
P10828; Q15596;
211-460
99.598HO;
THRb mutation with a novel agonist Heteromer
P10828; Q15596;
211-460
99.598HO;
A novel chemical derivative(56) of THRB agonist Heteromer
P10828; Q15596;
211-459
100.09II;
A novel chemical derivative(53) of THRB agonist Heteromer
P10828; Q15596;
211-459
100.09GC;
THRb mutation with a novel agonist Heteromer
P10828; Q15596;
211-459
99.598HO;
A novel chemical derivative(85) of THRB agonist Heteromer
P10828; Q15596;
211-459
100.09IQ;
THRb mutation with a novel agonist Heteromer
P10828; Q15596;
211-459
99.578HO;
A novel chemical derivative(71) of THRB agonist Heteromer
P10828; Q15596;
211-459
100.09IL;
A novel chemical derivative(52) of THRB agonist Heteromer
P10828; Q15596;
211-459
100.09IF;
RETINOID X RECEPTOR-THYROID HORMONE RECEPTOR DNA-BINDING DOMAIN HETERODIMER BOUND TO THYROID RESPON… Heteromer
P10828; P19793;
104-206
99.03ZN;
CRYSTAL STRUCTURE OF HUMAN TR BETA LIGAND-BINDING DOMAIN COMPLEXED WITH A POTENT SUBTYPE-SELECTIVE …homo-2-mer211-461
100.0PFA;
TR Variant D355Rhomo-2-mer210-460
99.594HY;SO4;
Thyroid receptor beta in complex with inhibitorhomo-2-mer210-460
99.594HY;LEG;SO4;
TR Receptor Mutations Conferring Hormone Resistance and Reduced Corepressor Release Exhibit Decreas…monomer202-461
99.64HY;ARS;
Structure of TR-beta bound to selective thyromimetic GC-1monomer202-461
100.0B72;
Human thyroid hormone receptor beta ligand binding domain in complex with beta-selective agonist AL…monomer202-461
100.0A1H2J;
TR Receptor Mutations Conferring Hormone Resistance and Reduced Corepressor Release Exhibit Decreas…monomer202-461
99.24HY;ARS;
Crystal Structure of T3-Bound Thyroid Hormone Receptormonomer202-460
100.0T3;
Two RTH Mutants with Impaired Hormone Bindingmonomer202-460
99.2NA;4HY;ARS;
Crystal Structure of TR-beta bound to the selective thyromimetic TRIACmonomer202-460
100.04HY;
Thyroxine-Thyroid Hormone Receptor Interactionsmonomer202-460
100.0CAC;T3;
Two RTH Mutants with Impaired Hormone Bindingmonomer202-460
99.194HY;
Thyroxine-Thyroid Hormone Receptor Interactionsmonomer202-460
100.0CAC;T44;
Crystal structure of the thyroid hormone receptor beta ligand binding domain in complex with a beta…monomer203-460
99.58442;
Crystal Structure of Human Thyroid Hormone Receptor beta LBD in complex with specific agonist GC-24monomer209-461
100.0G24;
Human Thyroid hormone receptor beta ligand binding domain in complex with KB131084monomer211-461
99.6OEF;
STRUCTURE AND SPECIFICITY OF NUCLEAR RECEPTOR-COACTIVATOR INTERACTIONSmonomer211-461
100.0T3;
Thyroid receptor beta1 in complex with a beta-selective ligandmonomer211-460
100IH5;

14 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5uan.1.Bmonomer0.64106-460
ZN;39.82
4nqa.2.Bmonomer0.61101-460
ZN;30.86
4nqa.1.Bmonomer0.61101-460
ZN;30.86
7wnh.4.Amonomer0.60107-461
ZN;30.15
7wnh.2.Amonomer0.60106-459
ZN;30.15
4nqa.1.Amonomer0.58102-460
ZN;26.99
3dzy.1.Bmonomer0.57104-461
ZN;30.46
7prw.1.Amonomer0.57103-461
ZN;19.64
4iqr.2.Amonomer0.57105-460
ZN;29.38
4iqr.2.Bmonomer0.57105-460
ZN;29.38
3dzy.1.Amonomer0.56104-459
ZN;26.77
5uan.1.Amonomer0.55105-460
ZN;26.99
7kw7.1.Fmonomer0.55220-461
19.70
7prw.1.Bmonomer0.55104-461
ZN;19.64